OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 122 filers reported holding OCULAR THERAPEUTIX INC in Q2 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $1,108,000 | -39.5% | 275,506 | -25.5% | 1.50% | -34.2% |
Q1 2022 | $1,830,000 | -38.7% | 369,628 | -13.6% | 2.28% | +3.1% |
Q4 2021 | $2,983,000 | -64.0% | 427,927 | -46.0% | 2.21% | -40.2% |
Q3 2021 | $8,275,000 | -6.5% | 792,775 | +27.0% | 3.70% | +3.2% |
Q2 2021 | $8,851,000 | +23.6% | 624,201 | +43.1% | 3.58% | +26.8% |
Q1 2021 | $7,160,000 | +397.6% | 436,307 | +527.8% | 2.82% | +275.7% |
Q4 2020 | $1,439,000 | +102.1% | 69,501 | -25.7% | 0.75% | +68.6% |
Q3 2020 | $712,000 | +115.8% | 93,587 | +24.8% | 0.45% | +38.1% |
Q2 2019 | $330,000 | – | 75,000 | – | 0.32% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SUMMER ROAD LLC | 6,122,089 | $19,223 | 100.00% |
Opaleye Management Inc. | 6,468,000 | $20,309,520 | 6.61% |
DELTEC ASSET MANAGEMENT LLC | 2,061,797 | $6,474,043 | 1.48% |
Endurant Capital Management LP | 353,707 | $1,110,640 | 1.00% |
SECTORAL ASSET MANAGEMENT INC | 969,350 | $3,043,759 | 0.59% |
NOTTINGHAM ADVISORS, INC. | 194,266 | $609,995 | 0.09% |
Covestor Ltd | 37,404 | $117 | 0.09% |
GSA CAPITAL PARTNERS LLP | 233,582 | $733 | 0.06% |
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 342,111 | $1,074,229 | 0.03% |
Polar Asset Management Partners Inc. | 263,763 | $828,216 | 0.02% |